These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 4890966)

  • 21. Radiological measurement of skin thickness and bone mineral.
    Doyle FH
    Sci Basis Med Annu Rev; 1969; ():133-45. PubMed ID: 4917833
    [No Abstract]   [Full Text] [Related]  

  • 22. Nighttime salivary cortisol: a useful test for the diagnosis of Cushing's syndrome.
    Papanicolaou DA; Mullen N; Kyrou I; Nieman LK
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4515-21. PubMed ID: 12364428
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Late-night salivary cortisol as a screening test for Cushing's syndrome.
    Raff H; Raff JL; Findling JW
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2681-6. PubMed ID: 9709931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The correlation between endocrine exophthalmos and exophthalmos producing substance (EPS).
    Schwarz F; Kinderen PJ der ; Houtstra-Lanz M
    Acta Endocrinol (Copenh); 1966 Mar; 51(3):359-68. PubMed ID: 5952376
    [No Abstract]   [Full Text] [Related]  

  • 25. Overnight suppression test with dexamethasone in Cushing's syndrome.
    Sawin CT; Bray GA; Idelson BA
    J Clin Endocrinol Metab; 1968 Mar; 28(3):422-4. PubMed ID: 4868264
    [No Abstract]   [Full Text] [Related]  

  • 26. Cushing's syndrome: new variants and association with empty sella syndrome.
    Mancini A; Calabrò F; Lagonigro G; Saporosi A; Colosimo C; Anile C; Maira G; De Marinis L
    J Nucl Med Allied Sci; 1990; 34(2):59-66. PubMed ID: 2246674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Corticotropin releasing hormone stimulation test: diagnostic aspects in Cushing's syndrome.
    Boscaro M; Rampazzo A; Sonino N; Merola G; Scanarini M; Mantero F
    J Endocrinol Invest; 1987 Jun; 10(3):297-302. PubMed ID: 3040851
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A reappraisal of the ovine corticotropin-releasing hormone stimulation test in the differential diagnosis of Cushing's syndrome: a comparison with the standard high-dose dexamethasone suppression test.
    Lee TI; Lin SY; Won JG; Tang KT; Jap TS; Kwok CF; Lin HD
    Zhonghua Yi Xue Za Zhi (Taipei); 2002 Oct; 65(10):474-82. PubMed ID: 12523812
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The corticotropin-releasing-hormone test versus the high-dose dexamethasone test in the differential diagnosis of Cushing's syndrome.
    Hermus AR; Pieters GF; Pesman GJ; Smals AG; Benraad TJ; Kloppenborg PW
    Lancet; 1986 Sep; 2(8506):540-4. PubMed ID: 2875282
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Diagnostic value of the L-dopa test].
    Migdalska B; Wiśniewska-Woźniak T; Baranowska B; Kasperlik-Zaluska A; Olesińska J
    Endokrynol Pol; 1976; 27(3):265-74. PubMed ID: 1278129
    [No Abstract]   [Full Text] [Related]  

  • 31. The metabolic effects of ACTH in a patient with Cushing's syndrome and acromegaly.
    ELIEL LP; PEARSON OH
    J Clin Endocrinol Metab; 1950 Jul; 10(7):822. PubMed ID: 15436601
    [No Abstract]   [Full Text] [Related]  

  • 32. Radon implantation for acromegaly and Cushing's syndrome.
    NORTHFIELD DW
    Proc R Soc Med; 1949 Oct; 42(10):845-53, illust. PubMed ID: 15406936
    [No Abstract]   [Full Text] [Related]  

  • 33. Coexisting acromegaly and Cushing's syndrome; discussion of hormone production by the pituitary acidophilic cell.
    McCORMICK RV; REED CE; MURRAY RH; RAY BS
    Am J Med; 1951 May; 10(5):662-70. PubMed ID: 14819069
    [No Abstract]   [Full Text] [Related]  

  • 34. Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome.
    Ghigo E; Arvat E; Ramunni J; Colao A; Gianotti L; Deghenghi R; Lombardi G; Camanni F
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2439-44. PubMed ID: 9253314
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Symptom complex of acromegaly and Itsenko-Cushing disease of primary diencephalic genesis].
    Gincherman EZ; Balabolin MI
    Probl Endokrinol Gormonoter; 1966; 12(3):3-6. PubMed ID: 4309838
    [No Abstract]   [Full Text] [Related]  

  • 36. [Cushing's syndrome and preclinical Cushing's syndrome].
    Nomura K; Hirohara D; Omori Y; Omori N; Takano K
    Nihon Rinsho; 2001 Dec; 59 Suppl 8():44-50. PubMed ID: 11808259
    [No Abstract]   [Full Text] [Related]  

  • 37. Alcohol-induced pseudo-Cushing's syndrome.
    Rees LH; Besser GM; Jeffcoate WJ; Goldie DJ; Marks V
    Lancet; 1977 Apr; 1(8014):726-8. PubMed ID: 66521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A combined test using desmopressin and corticotropin-releasing hormone in the differential diagnosis of Cushing's syndrome.
    Newell-Price J; Perry L; Medbak S; Monson J; Savage M; Besser M; Grossman A
    J Clin Endocrinol Metab; 1997 Jan; 82(1):176-81. PubMed ID: 8989255
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cushing's syndrome: analysis of 188 cases.
    Liou TC; Lam HC; Ho LT
    Taiwan Yi Xue Hui Za Zhi; 1989 Sep; 88(9):886-93. PubMed ID: 2621429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dynamic pituitary MRI has high sensitivity and specificity for the diagnosis of mild Cushing's syndrome and should be part of the initial workup.
    Friedman TC; Zuckerbraun E; Lee ML; Kabil MS; Shahinian H
    Horm Metab Res; 2007 Jun; 39(6):451-6. PubMed ID: 17578763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.